| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.02. | ADARx Pharmaceuticals Appoints Donald Fong as CMO | ||
| 05.02. | Sanofi 4Q Results | ||
| 05.02. | Braveheart Bio Promotes CSO, Names New SVP | ||
| 05.02. | AbbVie Submits Regulatory Applications for Rinvoq in Patients with Vitiligo | ||
| 04.02. | Novo Nordisk FY25 Results | ||
| 04.02. | OXB and BMS Expand Partnership With Lentiviral Vectors for CAR-T Programs | ||
| 04.02. | Merck 4Q Results | ||
| 04.02. | Biomica and Lishan Biotech Ink License Agreement for Microbiome-Based Cancer Therapeutic | ||
| 04.02. | HighRes, Opentrons to Launch First AI Agent-to-Agent Lab Workflow | ||
| 04.02. | Charles River Laboratories to Close Maryland Cell Therapy Site, Cut 20 Jobs | ||
| 04.02. | Thermo Fisher to Close Franklin, Mass. Site, Cut Up to 80 Jobs | ||
| 04.02. | Bracco Imaging Expands into the Cell Therapy Space | ||
| 04.02. | BioMedX Appoints Nico Frisch as VP, Site Head Heidelberg | ||
| 04.02. | Pharmagene Discovery Services Launches Human Tissue Lab Biz | ||
| 03.02. | CDR-Life Appoints Dimitrios Chondros as CMO | ||
| 03.02. | AGC Biologics Seattle Site Receives Anvisa GMP Certification | ||
| 03.02. | Spruce Biosciences Makes Two SVP Appointments | ||
| 03.02. | Cellares, Stanford University Partner to Expand Automated Manufacturing Beyond T Cell Therapies | ||
| 03.02. | Valo Health Names New CSO, Karin Conde-Knape | ||
| 03.02. | Cycle Group Holdings Acquires Applied Therapeutics | ||
| 03.02. | SK Bioscience, Gates MRI Partner to Advance RSV Preventive mAb Candidate | ||
| 02.02. | SEQSTER, Praxis Extend Partnership | ||
| 02.02. | Freudenberg Medical Launches LUBRITEQ High-Performance Hydrophilic Coating | ||
| 02.02. | Piramal Pharma Solutions Introduces Tablet-in-Capsule Drug Delivery System | ||
| 02.02. | J&J 4Q Results |